NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Infinity Bio, Inc.

Infinity Bio, Inc.

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.infinitybio.com/

Last Round

Series A

Jun 18, 2025

Est. Valuation

$32M

Total Funding Raised

$12.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Infinity Bio, Inc. is a biotechnology company that provides detailed insights into the immune system using its proprietary antibody reactome profiling platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

antibody profilingimmune profilingbiomarker discoveryMIPSAmolecular indexingautoimmunity profilingantibody reactomehigh-throughput sequencingtranslational medicineimmunology researchimmune mappingepitope mappingbiotech servicesproteomicsimmune repertoire

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Infinity Bio, Inc. Comparables

Compare Infinity Bio, Inc. with similar companies based on industry and business-model similarity.

Infinity Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Infinity Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 18, 2025
Early FundingOct 8, 2024

Key People

Founding team and executive leadership

Joy M. Nassif

Chief Executive Officer

Executive Team

Kelvin Liu

Chief Product Officer

Executive Team

Infinity Bio, Inc. Investors

Notable investors and investment history

Infinity Bio, Inc. investors
InvestorRounds
PTX CapitalSeries A, Early Funding
TCP Venture CapitalSeries A
TEDCOSeries A
Illumina VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 87% MoM.

  • Jun 18, 2025

    $8M round completed.

Infinity Bio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Infinity Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Infinity Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range22
Year Founded2023
Last FundingJun 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.